VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Invitation to Q1 2024 conference call
April 16, 2024 07:00 ET | Vistin Pharma ASA
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Mandatory notification of trade
March 22, 2024 16:59 ET | Vistin Pharma ASA
Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of NOK 22,10 per share. Espen W. Marcussen, Chair of the board in Pactum Vekst AS, is a primary insider and...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary)
March 04, 2024 02:15 ET | Vistin Pharma ASA
Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF Pharma Kft. CF Pharma is an API CDMO located in Budapest, Hungary with a broad customer base of recognized international...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Key information relating to the proposed cash dividend
February 16, 2024 04:30 ET | Vistin Pharma ASA
The Board of Directors of Vistin Pharma ASA plans to propose to distribute a cash dividend of total NOK 1.00 per share, to be paid partly in June and November, for the accounting year of 2023. The...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results
February 16, 2024 01:45 ET | Vistin Pharma ASA
Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma, OSE: VISTN) today announces the financial results for the fourth quarter of 2023. Vistin delivers another strong quarter with...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Invitation to Q4 2023 conference call
February 09, 2024 04:00 ET | Vistin Pharma ASA
Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and preliminary 2023 results on Friday 16th of February 2024. Vistin Pharma will host a conference call for all...
VistinPharma_Primary_White-background.jpg
Ex dividend NOK 0.75 today
January 23, 2024 02:00 ET | Vistin Pharma ASA
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024. ...
VistinPharma_Primary_White-background.jpg
Key information relating to the cash dividend to be paid by Vistin Pharma ASA
January 11, 2024 05:40 ET | Vistin Pharma ASA
Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024 Record date: 24 January 2024 Payment date: 30 January...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Dividend of NOK 0.75 per share
January 11, 2024 05:35 ET | Vistin Pharma ASA
Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for a dividend of NOK 0.75 per share. The dividend is...
VistinPharma_Primary_White-background.jpg
Vistin Pharma ASA: Third quarter 2023 financial results
October 25, 2023 01:45 ET | Vistin Pharma ASA
 Oslo, Norway, 25th of October 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter of 2023. Vistin delivers another strong quarter with...